Sonoma Pharmaceuticals, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
SNOA on Nasdaq
Location
5445 Conestoga Court, Suite 150, Boulder, CO

There are no Buy or Sell transactions made by insiders since 12/22/2023

Sonoma Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Mclaughlin Director Dec 29, 2022
Jay E. Birnbaum Director Dec 29, 2022
Jerome Dvonch Chief Financial Officer Jun 20, 2024
Amy Trombly Chief Executive Officer Jun 20, 2024
Philippe Weigerstorfer Director Dec 29, 2022
Bruce Thornton Executive Vice President Jun 20, 2024
Chad N. White Chief Financial Officer Dec 29, 2022
John Dal Controller Jun 20, 2024

Recent Insider Transactions by Companies or Individuals for Sonoma Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.